<DOC>
	<DOCNO>NCT00341159</DOCNO>
	<brief_summary>This study continue analyze data collect Women 's Contraceptive Reproductive Experiences ( CARE ) study . The CARE study design evaluate association reproductive factor risk breast cancer white African-American woman United States . The present study recruit additional participant . The original study enrol 4,575 woman breast cancer 4,682 control subject 35 64 year age All participant provide blood sample genetic study . The sample analyze variant ( mutation ) BRCA1 BRCA2 gene , vitamin D receptor gene , androgen receptor gene , insulin-like growth factor-1 gene . In addition , participant interview obtain information relate breast cancer risk , include history reproductive , menstrual , oral contraceptive , hormone replacement therapy use ; lifestyle factor smoke , alcohol use , body weight , physical activity ; history medical condition procedure ; demographic characteristic , age , race , marital status , forth ; detail family history cancer .</brief_summary>
	<brief_title>Analysis Data From Women 's Contraceptive Reproductive Experiences ( CARE ) Study</brief_title>
	<detailed_description>The purpose woman 's CARE study population base case control study design evaluate risk factor breast cancer among white African American woman age 35-64 United States . The study case U.S. born English-speaking woman newly diagnose pathologically confirm invasive breast cancer July 1994 April 1998 . Cases identify Surveillance , Epidemiology End Results ( SEER ) cancer registry center except Philadelphia ascertain field staff local hospital . African-American woman sample , young case patient maximize number stratum . Older white case patient randomly sample provide approximately equal number patient 5-year age category . A total 4575 case interview include 2953 white woman 1622 African American woman . Controls U.S. bear English-speaking woman never diagnose invasive situ breast cancer identify random digit dialing . Controls frequency-matched case study center , race , five-year age group . A total 4682 control interviewed 3021 white 1661 African American . Information collect similarly case control focus factor potentially relate risk breast cancer , include , reproductive , menstrual , oral contraceptive ( OC ) Hormone Replacement Therapy ( HRT ) use history ; lifestyle factor smoke , alcohol use , body weight , physical activity ; select history medical condition procedure ; demographic characteristic ; detail family history cancer . A total 1652 Cases 1453 control provide high quality DNA form blood sample . The Ostrander lab 's role study screen complete cod region , well intron-exon boundary 1652 case 600 control mutation BRCA1 BRCA2 gene use denature high performance liquid chromatograph ( DHPLC ) direct sequence . In addition screen 1652 case 1453 control germline variant androgen receptor ( AR ) , Insulin Like Growth Factor-1 ( IGF-1 ) vitamin D receptor ( VDR ) gene . The lab work study complete , analysis currently underway . This IRB file include request additional lab work . The focus request continue analysis complete lab work collaboration data-coordinating center Fred Hutchinson Cancer Research Center . Data coordination lead Drs . Kathleen Malone Janet Daling Public Health Sciences Division FHCRC .</detailed_description>
	<criteria>Original recruitment case identify Surveillance , Epidemiology End Results ( SEER ) cancer registry several year ago data set . Accrual complete .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 24, 2015</verification_date>
	<keyword>Breast</keyword>
	<keyword>BRCA1</keyword>
	<keyword>BRCA2</keyword>
	<keyword>Inherited</keyword>
	<keyword>Association</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Population-Based</keyword>
	<keyword>Cancer Susceptibility Alleles</keyword>
</DOC>